Independent radiologic review of GOG218, a phase III trial of bevacizumab (BEV) in the primary treatment of advanced epithelial ovarian (EOC), primary peritoneal (PPC) or Fallopian tube cancer (FTC).
R. A. Burger
Consultant or Advisory Role - Genentech (U)
M. F. Brady
Research Funding - Genentech
J. Rhee
Employment or Leadership Position - Genentech
Stock Ownership - Roche
M. A. Sovak
Employment or Leadership Position - Genentech
Stock Ownership - Roche
H. Nguyen
Employment or Leadership Position - Genentech
Stock Ownership - Roche
M. A. Bookman
Employment or Leadership Position - Boehringer Ingelheim; Genentech
Consultant or Advisory Role - Genentech
Stock Ownership - Roche